Non-medullary Thyroid Cancer Susceptibility Genes: Evidence and Disease Spectrum

Jingan Zhou,Preeti Singh,Kanhua Yin,Jin Wang,Yujia Bao,Menghua Wu,Kush Pathak,Sophia K. McKinley,Danielle Braun,Carrie C. Lubitz,Kevin S. Hughes
DOI: https://doi.org/10.1245/s10434-021-09745-x
IF: 4.339
2021-03-03
Annals of Surgical Oncology
Abstract:The prevalence of non-medullary thyroid cancer (NMTC) is increasing worldwide. Although most NMTCs grow slowly, conventional therapies are less effective in advanced tumors. Approximately 5–15% of NMTCs have a significant germline genetic component. Awareness of the NMTC susceptibility genes may lead to earlier diagnosis and better cancer prevention.
oncology,surgery
What problem does this paper attempt to address?